DAFNA Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Buy
430,248
+11,993
+3% +$93.1K 0.93% 30
2025
Q4
$3.26M Buy
418,255
+200,000
+92% +$1.45M 0.76% 35
2025
Q3
$1.66M Hold
218,255
0.41% 50
2025
Q2
$1.96M Sell
218,255
-340,000
-61% -$3.17M 0.54% 38
2025
Q1
$4.19M Sell
558,255
-108,745
-16% -$877K 1.19% 24
2024
Q4
$5.02M Hold
667,000
1.28% 21
2024
Q3
$5.07M Sell
667,000
-37,500
-5% -$285K 1.2% 23
2024
Q2
$4.35M Sell
704,500
-5,000
-0.7% -$27.6K 1.04% 27
2024
Q1
$3.6M Hold
709,500
0.82% 33
2023
Q4
$4.25M Buy
709,500
+57,500
+9% +$333K 1.02% 33
2023
Q3
$4.62M Buy
652,000
+83,000
+15% +$596K 1.44% 22
2023
Q2
$4.01M Buy
569,000
+17,500
+3% +$140K 1.1% 29
2023
Q1
$4.6M Buy
551,500
+300,500
+120% +$2.89M 1.38% 25
2022
Q4
$2.88M Buy
+251,000
New +$3.13M 0.81% 37
2020
Q4
Sell
-749,051
Closed -$2.57M 79
2020
Q3
$2.57M Buy
749,051
+5,000
+0.7% +$21.4K 0.84% 36
2020
Q2
$3.54M Buy
744,051
+265,000
+55% +$1.06M 1.02% 30
2020
Q1
$958K Sell
479,051
-35,000
-7% -$96.4K 0.4% 49
2019
Q4
$1.77M Buy
514,051
+30,663
+6% +$77.1K 0.61% 38
2019
Q3
$1.39M Buy
483,388
+72,500
+18% +$226K 0.52% 50
2019
Q2
$1.56M Sell
410,888
-87,527
-18% -$527K 0.59% 48
2019
Q1
$4.06M Buy
498,415
+34,000
+7% +$291K 1.75% 19
2018
Q4
$3.75M Sell
464,415
-187,671
-29% -$1.46M 1.86% 18
2018
Q3
$4.97M Buy
652,086
+47,434
+8% +$319K 2.04% 15
2018
Q2
$3.46M Sell
604,652
-370,000
-38% -$2.04M 1.62% 21
2018
Q1
$4.65M Sell
974,652
-218,576
-18% -$1.12M 2.26% 15
2017
Q4
$5.86M Hold
1,193,228
3.16% 7
2017
Q3
$6.25M Buy
1,193,228
+602,100
+102% +$3.08M 3.88% 5
2017
Q2
$3.29M Buy
591,128
+50,000
+9% +$305K 2.35% 7
2017
Q1
$4.54M Buy
541,128
+475,228
+721% +$3.31M 3.84% 5
2016
Q4
$417K Buy
+65,900
New +$343K 0.37% 55
2016
Q2
Sell
-149,642
Closed -$423K 96
2016
Q1
$423K Sell
149,642
-106,000
-41% -$470K 0.36% 67
2015
Q4
$2.64M Sell
255,642
-3,000
-1% -$29.8K 2.35% 13
2015
Q3
$2.95M Buy
258,642
+36,986
+17% +$494K 2.93% 6
2015
Q2
$3.31M Buy
221,656
+55,000
+33% +$625K 2.8% 7
2015
Q1
$1.5M Hold
166,656
1.16% 25
2014
Q4
$2.03M Buy
166,656
+90,256
+118% +$997K 1.6% 19
2014
Q3
$747K Buy
+76,400
New +$936K 0.75% 32

Other funds holding BCRX